Plasma Visfatin Concentrations in Subjects with Type 1 Diabetes Mellitus

Hormone Research

Volumn 72, Issue 1, 2009, Pages 33-37

  Toruner, F ^a   Altinova, A E ^a,d   Bukan, N ^a   Arslan, E ^a   Akbay, E ^c   Ersoy, R ^b   Arslan, M ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c MERSIN UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Diabetes duration; Hemoglobin A1c; Lipids; Type 1 diabetes mellitus; Visfatin

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 67651092154     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000224338     Document Type: Article

References (24)

1. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
2. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-430.
3. Pilz S, Mangge H, Obermayer-Pietsch B, März W: Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. J Endocrinol Invest 2007;30:138-144.
4. Beltowski J: Apelin and visfatin: unique 'beneficial' adipokines upregulated in obesity? Med Sci Monit 2006;12:RA112-RA119.
5. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M: Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005;185:R1-R8.
6. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M: Inter-leukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005;289:E586-E590.
7. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T: Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007;56:451-458.
8. Haider DG, Schindler K, Schaller G, Prager G, Wol zt M, Ludvi k B: Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006;91:1578-1581.
9. Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S, Ozgurtas T, Bingol S: Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007;76:24-29.
10. López-Bermejo A, Chico-Julià B, Fernàn-dez-Balsells M, Recasens M, Esteve E, Casamitjana R, Ricart W, Fernández-Real JM: Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006;55:2871-2875.
11. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G: Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006;110:605-609.
12. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, Milan G, Rossato M, Federspil G, Vettor R: Reduced plasma visfatin/ pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006;91:3165-3170.
13. Haider DG, Pleiner J, Francesconi M, Wie-singer GF, Muller M, Wolzt M: Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab 2006;91:4702-4704.
14. Expert Committee on the Diagnosis and Classificiation of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1):43-48.
15. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, Li K: Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006;114:544-548.
16. Chan TF, Chen YL, Lee CH, Chou FH, Wu LC, Jong SB, Tsai EM: Decreased plasma visfatin concentrations in women with gestational diabetes mellitus. J Soc Gynecol Investig 2006;13:364-367.
17. Kloting N, Kloting I: Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 2005;332:1070-1072.
18. Manco M, Fernandez-Real JM, Equitani F, Vendrell J, Valera Mora ME, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M, Mingrone G: Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 2007;92:483-490.
19. Krzyzanowska K, Mittermayer F, Krugluger W, Kopp HP, Schernthaner G: Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 2006;14:1886-1889.
20. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M: Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005;54:2911-2916.
21. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M: The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006;49:1909-1914.
22. Smith J, Al-Amri M, Sniderman A, Cianflone K: Visfatin concentration in Asian Indians is correlated with high density lipoprotein cholesterol and apolipoprotein A1. Clin Endocrinol (Oxf) 2006;65:667-672.
23. Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M, Han JF, Zhao Y, Li G, Luo M: The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet Med 2006;23:967-973.
24. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ: Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-299.